Search Results
Is TP53-mutated high-risk MDS the same disease as TP53-mutated AML?
An analysis of TP53 mutation in AML and HR-MDS
Dr. Pemmaraju on the Challenges of Targeting TP53 Mutations in MDS/AML
The association between prior exposure to lenalidomide and TP53-mutated AML/MDS
Options available to patients with TP53-mutated MDS beyond stem cell transplantation
Magrolimab in TP53 mutated AML and MDS
Outcomes of alloHSCT in TP53-mutated AML and MDS
TP53-Mutant AML: A Pathology-Guided Journey Through Diagnostic Principles
The benefit of allogeneic transplantation in patients with TP53-mutated AML
Should patients with TP53-mutated MDS receive stem cell transplant?
Challenges in treating patients with TP53-mutated AML and future outlooks
APR-246 in TP53 mutated MDS and AML
